Westside Investment Management’s Avidity Biosciences RNAM Stock Holding History

Westside Investment Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,633	Closed	-$118K	–	1522
2025 Q4	$118K	Sell	1,633 -433	-21%	-$28K	0.02%	366
2025 Q3	$88.8K	Buy	2,066 +1,033	+100%	+$41.8K	0.01%	412
2025 Q2	$29.4K	Buy	+1,033	New	+$30.8K	0.01%	569

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Westside Investment Management's RNAM Position: Q1 2026 in Review

Westside Investment Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 1,633 shares — an estimated $118K sold.

Westside Investment Management first reported a position in RNAM in Q2 2025 and held it in 3 quarters. The position peaked at $118K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Westside Investment Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Westside Investment Management sold 1,633 Avidity Biosciences shares in Q1 2026, an estimated $118K.
Westside Investment Management first reported a position in Avidity Biosciences in Q2 2025 and held it in 3 quarters.
Westside Investment Management's Avidity Biosciences position peaked at $118K in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Westside Investment Management's 13F filing for Q1 2026, filed 4 May 2026.